Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark L Metersky

Showing results (11-20 of 137) with videos related to

Pageof 14
Sort By:
American Journal of Respiratory and Critical Care Medicine|August 12, 2021
Fewer Bronchiectasis Exacerbations during the "Lockdown" for COVID-19: Can We Convert Knowledge into Action?Mark L Metersky
Current Opinion in Infectious Diseases|January 27, 2026
Anti-inflammatory therapies for bronchiectasisJennifer Bautista, Mark L Metersky
Expert Review of Anti-Infective Therapy|October 7, 2009
A comparison of linezolid with glycopeptides in severe MRSA pneumoniaJafar Abunasser, Mark L Metersky
Connecticut Medicine|July 28, 2006
The significance of parapneumonic pleural effusions developing during antibiotic treatment for pneumoniaMadalina Macrea, Mark L Metersky
Chest|February 22, 2021
The Association of Long-term Macrolide Therapy and Nontuberculous Mycobacterial Culture Positivity in Patients With BronchiectasisMark L Metersky, Radmila Choate,
Journal of Thoracic Disease|October 18, 2016
Chronic suppurative lung disease in adultsMark L Metersky, Antranik Mangardich
Respirology (Carlton, Vic.)|October 6, 2010
Tracheal aspirate Gram stain has limited sensitivity and specificity for detecting Staphylococcus aureusSodienye Tetenta, Mark L Metersky
Chest|February 9, 2012
Introducing the future of ACCP Clinical Practice GuidelinesMark L Metersky, Ian Nathanson
Connecticut Medicine|February 8, 2012
Mycobacterium nebraskense as a cause of nodular pulmonary diseaseSwathy Puthalapattu, Mark L Metersky
Life (Basel, Switzerland)|November 27, 2021
Telemedicine and Remote Monitoring as an Adjunct to Medical Management of BronchiectasisSoontharee Congrete, Mark L Metersky
Pageof 14

Showing results (11-20 of 137) with videos related to

Sort By:
Pageof 14
American Journal of Respiratory and Critical Care Medicine|August 12, 2021
Fewer Bronchiectasis Exacerbations during the "Lockdown" for COVID-19: Can We Convert Knowledge into Action?Mark L Metersky
Current Opinion in Infectious Diseases|January 27, 2026
Anti-inflammatory therapies for bronchiectasisJennifer Bautista, Mark L Metersky
Expert Review of Anti-Infective Therapy|October 7, 2009
A comparison of linezolid with glycopeptides in severe MRSA pneumoniaJafar Abunasser, Mark L Metersky
Connecticut Medicine|July 28, 2006
The significance of parapneumonic pleural effusions developing during antibiotic treatment for pneumoniaMadalina Macrea, Mark L Metersky
Chest|February 22, 2021
The Association of Long-term Macrolide Therapy and Nontuberculous Mycobacterial Culture Positivity in Patients With BronchiectasisMark L Metersky, Radmila Choate,
Journal of Thoracic Disease|October 18, 2016
Chronic suppurative lung disease in adultsMark L Metersky, Antranik Mangardich
Respirology (Carlton, Vic.)|October 6, 2010
Tracheal aspirate Gram stain has limited sensitivity and specificity for detecting Staphylococcus aureusSodienye Tetenta, Mark L Metersky
Chest|February 9, 2012
Introducing the future of ACCP Clinical Practice GuidelinesMark L Metersky, Ian Nathanson
Connecticut Medicine|February 8, 2012
Mycobacterium nebraskense as a cause of nodular pulmonary diseaseSwathy Puthalapattu, Mark L Metersky
Life (Basel, Switzerland)|November 27, 2021
Telemedicine and Remote Monitoring as an Adjunct to Medical Management of BronchiectasisSoontharee Congrete, Mark L Metersky
Pageof 14